Public equity research

Public stock research with clear valuation work.

Read US equity notes with a clear rating, target price, DCF/WACC assumptions, peer context, and risk framing. Join free alerts for new coverage, rating changes, target changes, and valuation assumption updates.

US listed equities onlyDCF and peer checksReviewed before publication

Research Alerts

Know when a public note is published, refreshed, or materially changed.

Alerts focus on concrete research events: new coverage, rating changes, target changes, and valuation assumption updates.

Latest NoteHOLD

V at $292.12

Visa Inc. screens HOLD with a blended target price of $292.12, versus a current price of $319.67 and modeled upside of -8.6%.

6/9/2026Target $292.12Upside -8.6%
Open V stock analysis
Methodology, sources, and dates stay visibleReviewed before publicationDCF, WACC, peer context, and risks remain publicInformation only, never personalized advice

Latest public research

Published notes stay available as structured, linkable pages with valuation, DCF/WACC, risks, methodology, and disclaimer visible.

Browse all reports

Request coverage

Missing a name you follow? Send the ticker and email. If it fits the coverage scope, you will get an email when the public note is published or refreshed.

Editorial Pipeline

Near-term refreshes and coverage work selected by data freshness, reader interest, and research usefulness.

ConocoPhillips long-term outlook and price target report

Refresh ConocoPhillips long-term investment outlook, growth prospects, price target, and peer context.

GSC refresh
Honeywell revenue growth and price target report

Refresh Honeywell revenue growth, net income trend, long-term prospects, and price target framing.

GSC refresh
Broadcom WACC and stock valuation report

Refresh Broadcom WACC, stock valuation, peer multiples, and price target context.

GSC refresh
Nike WACC and stock valuation report

Refresh Nike WACC, cost of capital, and stock valuation framing.

CTR refresh
Pfizer DCF valuation and EV/EBITDA report

Refresh Pfizer DCF valuation, intrinsic value, EV/EBITDA, and upside framing.

CTR refresh
Uber EV/revenue and EV/EBITDA valuation report

Refresh Uber EV/revenue, EV/EBITDA, P/E, and valuation assumptions.

CTR refresh
Meta WACC estimate and intrinsic value report

Refresh Meta WACC estimate 2026, intrinsic value, fair value, and valuation framing.

CTR refresh

How the notes are built

The research note comes first. Pro helps readers track changes around the same public work, instead of locking the core valuation behind a paywall.

Valuation upfront

Each note opens with the rating, target price, current price, upside/downside, and the valuation anchor behind the call.

Assumptions visible

DCF value per share, WACC, terminal growth, peer midpoint, sensitivity, methodology, data dates, and risks remain public.

Change tracking

Pro adds watchlists, weekly digest, revision history, exports, and alerts for target, rating, and valuation assumption changes.

Valuation guides for stock research

Short primers explain the valuation language used in the public notes.